Cargando…
Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1
Anti-tumor drug resistance is a challenge for human triple-negative breast cancer (TNBC) treatment. Our previous work demonstrated that TNFAIP2 activates RAC1 to promote TNBC cell proliferation and migration. However, the mechanism by which TNFAIP2 activates RAC1 is unknown. In this study, we found...
Autores principales: | Fang, Huan, Ren, Wenlong, Cui, Qiuxia, Liang, Huichun, Yang, Chuanyu, Liu, Wenjing, Wang, Xinye, Liu, Xue, Shi, Yujie, Feng, Jing, Chen, Ceshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547475/ https://www.ncbi.nlm.nih.gov/pubmed/37787041 http://dx.doi.org/10.7554/eLife.88483 |
Ejemplares similares
-
Angiopoietin-1 promotes triple-negative breast cancer cell proliferation by upregulating carboxypeptidase A4: ANG1-CPA4 axis promotes TNBC progression
por: Liu, Xue, et al.
Publicado: (2023) -
Plastin 1 drives metastasis of colorectal cancer through the IQGAP1/Rac1/ERK pathway
por: Zhang, Tongtong, et al.
Publicado: (2020) -
The roles of TNFAIP2 in cancers and infectious diseases
por: Jia, Lin, et al.
Publicado: (2018) -
TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1
por: Pang, Yihua, et al.
Publicado: (2020) -
RCP-driven α5β1 recycling suppresses Rac and promotes RhoA activity via the RacGAP1–IQGAP1 complex
por: Jacquemet, Guillaume, et al.
Publicado: (2013)